市場調查報告書

大麻製劑的市場規模:市場佔有率·趨勢分析·不同品牌(Epidiolex,Sativex),各地區的市場區隔預測(2020年∼2027年)

Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand (Epidiolex, Sativex), By Region (North America, Europe, Asia Pacific, Latin America & MEA), And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 940818
出版日期 內容資訊 英文 80 Pages
商品交期: 2-3個工作天內
價格
大麻製劑的市場規模:市場佔有率·趨勢分析·不同品牌(Epidiolex,Sativex),各地區的市場區隔預測(2020年∼2027年) Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand (Epidiolex, Sativex), By Region (North America, Europe, Asia Pacific, Latin America & MEA), And Segment Forecasts, 2020 - 2027
出版日期: 2020年05月26日內容資訊: 英文 80 Pages
簡介

全球大麻製劑的市場規模在預測期間內預計將以76.8%的年複合成長率增長,2027年達到58億美元的規模。該市場成長的主要因素有具治療效果臨床試驗的增加,對植物製大麻二酚產品的醫療效果認識不斷提升等。

本報告提供全球大麻製劑市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,品牌·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查手法和範圍

第2章 摘要整理

第3章 市場變數,趨勢及規模

  • 市場區隔
  • 市場動態
  • 滲透與成長預測的製圖
  • 全球大麻製劑的法規方案
  • PESTEL分析
  • 波特的五力分析
  • 5個替代威脅
  • 市場機會分析
  • 各階段的產品平台分析
  • 主要交易與策略性聯盟
  • 合成大麻醫藥品概要

第4章 市場分析:不同品牌

  • 市場規模預測·趨勢分析
    • Sativex
    • Epidiolex

第5章 市場分析:各地區

  • 市場佔有率
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第6章 競爭情形

  • 企業簡介
  • 主要新興企業一覽
  • 企業的分類
  • 企業的市場上地位
  • 企業的市場佔有率分析
  • 市場差異化
目錄
Product Code: GVR-4-68038-473-4

Cannabis Pharmaceuticals Market Growth & Trends

The global cannabis pharmaceuticals market size is projected to reach USD 5.8 billion by 2027, expanding at a CAGR of 76.8% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of clinical trials for these drugs due to its therapeutic properties, growing awareness of the medical benefits of plant-derived cannabidiol products are some of the factors driving the demand over the forecast period. However, the presence of stringent regulations on cannabidiol-infused products in various countries is restricting demand for these products.

In 2019, Sativex is the leading brand in the global market with a revenue share of 83.0%. The surge in clinical trials for numerous medical conditions and the growing number of countries legalizing cannabis for medical purposes are the major factors responsible for its large share. On the other hand, Epidiolex is anticipated to be the fastest-growing brand over the forecast period. Growing research for plant-based cannabinoids for other rare conditions is expected to drive the growth of this segment over the forecast period.

The European region is expected to dominate the market in 2019, owing to growing medical marijuana users in the region coupled with the rising awareness about cannabidiol infused products. On the other hand, the Asia Pacific region is expected to grow at the fastest rate over the forecast period owing to growing legalization and favorable guidelines towards the use of cannabidiol infused pharma products in the region.

Cannabis Pharmaceuticals Market Report Highlights

In 2019, Sativex is estimated to dominate the market with a revenue share of 83.0%, due to the growing number of countries legalization of plant-derived pharma products for medical purpose

In terms of revenue, U.S. was the largest country level market. U.S.FDA's approval of Epidiolox and high adoption of this drug are few factors for the country's large share.

Some of the major players operating in this cannabis pharmaceuticals market are GW Pharmaceuticals, AbbVie Inc., Valeant Pharmaceuticals, and Insys Therapeutics, Inc.

Table Of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
    • 1.3.1 Region Market: CAGR Calculation
  • 1.4 Region Based Segment Share Calculation
  • 1.5 List of Secondary Sources
  • 1.6 List of Primary Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Cannabis Pharmaceuticals Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Penetration & Growth Prospects Mapping
  • 3.4 Global Cannabis Pharmaceuticals Regulatory Scenario
  • 3.5 Cannabis Pharmaceuticals - PESTEL Analysis
    • 3.5.1. Political
    • 3.5.2. Environmental
    • 3.5.3 Social
    • 3.5.4 Technology
    • 3.5.5. Legal
    • 3.5.6 Economic
  • 3.6 Cannabis Pharmaceuticals - Porter's Analysis
    • 3.6.1. Threat of New Entrants
    • 3.6.2 Bargaining Power of Buyers
    • 3.6.3 Competitive Rivalry
    • 3.6.4 Bargaining Power of Suppliers
  • 3.6. 5 Threat of Substitutes
  • 3.7 Opportunity Analysis (2016 - 2019-2027)
  • 3.8 Product Pipeline Analysis, By Stage
  • 3.9 Key Deals and Strategic Aliances
  • 3.10 Synthetic Cannabis Pharmaceuticals Overview

Chapter 4 Cannabis Pharmaceuticals Market: Brand Estimates & Trend Analysis

  • 4.1 Cannabis Pharmaceuticals Market Size & Forecasts And Trend Analysis By Brand, 2016 - 2027, (USD Million)
    • 4.1.1 Sativex
      • 4.1.1.1 Sativex Market Estimates and Forecasts, 2016 - 2027 (USD Million)
    • 4.1.2 Epidiolex
      • 4.1.2.1 Epidiolex Market Estimates and Forecasts, 2016 - 2027 (USD Million)

Chapter 5 Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis

  • 5.1 Global Cannabis Pharmaceuticals Market Share, By Country, 2019 & 2027
    • 5.1.1 North America
      • 5.1.1.1 North America Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.1.2 U.S.
      • 5.1.1.2.1 U.S. Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.1.3 Canada
      • 5.1.1.3.1 Canada Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
    • 5.1.2 Europe
      • 5.1.2.1 Europe Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.2 U.K.
      • 5.1.2.2.1 U.K. Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.3 Germany
      • 5.1.2.3.1 Germany Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.4 Italy
      • 5.1.2.4.1 Italy Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.5 France
      • 5.1.2.5.1 France Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.6 Netherlands
      • 5.1.2.6.1 Netherlands Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.7 Poland
      • 5.1.2.7.1 Poland Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.8 Croatia
      • 5.1.2.8.1 Croatia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.9 Czech Republic
      • 5.1.2.9.1 Czech Republic Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.2.10 Switzerland
      • 5.1.2.10.1 Switzerland Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
    • 5.1.3 Asia Pacific
      • 5.1.3.1 Asia Pacific Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.3.2 Japan
      • 5.1.3.2.1 Japan Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.3.3 South Korea
      • 5.1.3.3.1 South Korea Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.3.4 Australia
      • 5.1.3.4.1 Australia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.3.5 New Zealand
      • 5.1.3.5.1 New Zealand Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
    • 5.1.4 Latin America
      • 5.1.4.1 Latin America Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.2 Brazil
      • 5.1.4.2.1 Brazil Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.3 Mexico
      • 5.1.4.3.1 Mexico Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.4 Argentina
      • 5.1.4.4.1 Argentina Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.5 Colombia
      • 5.1.4.5.1 Colombia Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.6 Uruguay
      • 5.1.4.6.1 Uruguay Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.4.7 Chile
      • 5.1.4.7.1 Chile Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
    • 5.1.5 Middle East & Africa
      • 5.1.5.1 Middle East & Africa Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
      • 5.1.5.2 Israel
      • 5.1.5.2.1 Israel Cannabis Pahrmaceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Company Profiles
    • 6.1.1 GW Pharmaceuticals
      • 6.1.1.1 Company Overview
      • 6.1.1.2 Financial Performance
      • 6.1.1.3 Product Offerings
      • 6.1.1.4 Strategic Initiatives
    • 6.1.2 AbbVie Inc.
      • 6.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 6.1.2.3 Product Offerings
      • 6.1.2.4 Strategic Initiatives
    • 6.1.3 Valeant Pharmaceuticals
      • 6.1.3.1 Company Overview
      • 6.1.3.2 Financial Performance
      • 6.1.3.3 Product Offerings
      • 6.1.3.4 Strategic Initiatives
    • 6.1.4 Insys Therapeutics, Inc.
      • 6.1.4.1 Company Overview
      • 6.1.4.2 Financial Performance
      • 6.1.4.3 Product Offerings
      • 6.1.4.4 Strategic Initiatives
  • 6.2 List of Key Emerging Players
  • 6.3 Company Categorization
  • 6.4 Company Market Position Analysis
  • 6.5 Company Market Share Analysis, 2019
  • 6.6 Market Differentiators

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of primary sources
  • Table 3 North America Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 4 North America Cannabis Pharmaceuticals market, by sales channel, 2016 - 2027 (USD Million)
  • Table 5 U.S. Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 6 Canada Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 7 Europe Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 8 U.K. Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 9 Germany Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 10 France Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 11 Italy Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 12 Croatia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 13 Netherlands Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 14 Poland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 15 Switzerland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 16 Czech Republic Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 17 Switzerland Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 18 Asia Pacific Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 19 Japan Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 20 South Korea Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 21 Australia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 22 New Zealand Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 23 Brazil Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 24 Mexico Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 25 Argentina Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 26 Colombia Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 27 Uruguay Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 28 Chile Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)
  • Table 29 Israel Cannabis Pharmaceuticals market, by brand, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cannabis Pharmaceuticals market snapshot, 2019 (USD Million)
  • Fig. 9 Cannabis Pharmaceuticals market segmentation
  • Fig. 10 Cannabis Pharmaceuticals market dynamics
  • Fig. 11 Cannabis Pharmaceuticals market driver impact
  • Fig. 12 Cannabis Pharmaceuticals market restraints impact
  • Fig. 13 Penetration & growth prospects mapping for Cannabis Pharmaceuticals market
  • Fig. 14 Cannabis Pharmaceuticals -PESTL Analysis
  • Fig. 15 Cannabis Pharmaceuticals -PORTER's Analysis
  • Fig. 16 Opportunity analysis (USD Million)
  • Fig. 17 Cannabis Pharmaceuticals market, brand outlook: Key takeaways
  • Fig. 18 North America Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 19 U.S. Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 20 CanadaCannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 21 Europe Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 22 U.K. Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 23 Germany Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 24 France Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 25 Italy Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 26 Netherlands Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 27 Poland Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 28 Croatia Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 29 Switzerland Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 30 Czech Republic Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 31 Asia Pacific Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 32 Japan Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 33 South Korea Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 34 Australia Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 35 New Zealand Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 36 Brazil Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 37 Mexico Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 38 Argentina Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 39 Colombia Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 40 Uruguay Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 41 Chile Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 42 Israel Cannabis Pharmaceuticals market estimates and forecasts, 2016 - 2027 (USD Million)